SCHEMBL22662015

SCHEMBL22662015

c1ccc(-n2c3ccccc3n3c4cc(-c5ccc6nc7n(-c8ccccc8)c8ccccc8n7c6c5)ccc4nc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.44
ADORA1 P30542 3/20 0.44
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
GRIA1 P42261 1/20 0.37
CACNG8 Q8WXS5 1/20 0.37
CACNG2 Q9Y698 1/20 0.37
ADORA2A P29274 1/20 0.36
ALDH1A1 P00352 3/20 0.36
RECQL P46063 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
HCAR1 Q9BXC0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21965598 0.97 ADORA2B (0.46) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662016 0.96 ADORA2B (0.45) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662005 0.94 MAPK1 (0.42) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662205 0.93 ADORA2B (0.43) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22357652 0.92 ADORA2B (0.42) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662003 0.91 ADORA2B (0.42) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662014 0.91 ESR1 (0.43) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662009 0.90 ESR1 (0.42) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL23652466 0.89 KDM4E (0.45) ADORA2BADORA1MAPK1HTTESR1
SCHEMBL22662156 0.89 ADORA2B (0.40) ADORA2BADORA1MAPK1HTTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840459-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10840459-B2 Organic electroluminescent materials and devices L1CAM, CHRM1, C1S ADORA2B 505/4885ADORA1 469/4885MAPK1 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.